K

KalVista Pharmaceuticals
D

KALV

10.020
USD
-0.62
(-5.83%)
مغلق
حجم التداول
14,304
الربح لكل سهم
-4
العائد الربحي
-
P/E
-3
حجم السوق
495,168,220
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: KalVista Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.